ST Pharm Co.,Ltd. (KOSDAQ:237690)

ST Pharm Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	298,109	273,751	284,992	249,322	165,642	124,109
Other Revenue	-0	-0	-	-0	-0	-
Revenue	298,109	273,751	284,992	249,322	165,642	124,109
Revenue Growth (YoY)	9.24%	-3.94%	14.31%	50.52%	33.47%	33.08%
Cost of Revenue	187,834	180,147	175,248	162,140	110,333	105,760
Gross Profit	110,275	93,605	109,744	87,182	55,309	18,349
Selling, General & Admin	40,501	40,069	41,120	37,665	28,034	19,496
Research & Development	22,677	22,108	30,450	26,306	18,218	13,204
Other Operating Expenses	261.17	464.7	1,069	863.35	761.82	1,820
Operating Expenses	67,459	65,912	76,232	69,330	49,731	37,166
Operating Income	42,816	27,693	33,512	17,851	5,578	-18,817
Interest Expense	-7,738	-7,738	-6,106	-2,868	-5,157	-644.58
Interest & Investment Income	4,571	4,571	2,440	1,236	939.37	618.04
Earnings From Equity Investments	-246.09	-246.09	-	-	-	-
Currency Exchange Gain (Loss)	13,298	13,298	1,809	3,607	3,361	-1,922
Other Non Operating Income (Expenses)	-20,872	-5,823	-236.68	683.87	65.55	693.3
EBT Excluding Unusual Items	31,829	31,755	31,418	20,511	4,786	-20,072
Gain (Loss) on Sale of Investments	12,390	12,390	-8,063	-628.83	147.24	3,258
Gain (Loss) on Sale of Assets	-1,446	-1,446	-0.62	-644.73	-3,673	-10.89
Asset Writedown	47.79	47.79	-	-	-	-
Pretax Income	42,821	42,747	23,354	19,237	1,260	-16,825
Income Tax Expense	10,611	10,283	5,831	1,721	-2,117	-3,670
Earnings From Continuing Operations	32,210	32,464	17,523	17,516	3,377	-13,155
Minority Interest in Earnings	1,726	2,248	2,058	484.29	-65.27	1,008
Net Income	33,935	34,712	19,581	18,000	3,312	-12,147
Net Income to Common	33,935	34,712	19,581	18,000	3,312	-12,147
Net Income Growth	56.34%	77.27%	8.78%	443.46%	-	-
Shares Outstanding (Basic)	20	20	19	19	19	19
Shares Outstanding (Diluted)	20	20	19	19	19	19
Shares Change (YoY)	6.71%	3.70%	-	0.77%	0.05%	-
EPS (Basic)	1686.52	1779.72	1041.07	957.00	177.50	-651.11
EPS (Diluted)	1686.52	1779.72	1041.00	957.00	177.00	-651.11
EPS Growth	46.52%	70.96%	8.78%	440.68%	-	-
Free Cash Flow	-8,032	26,646	-41,946	-53,448	-44,522	-37,924
Free Cash Flow Per Share	-399.17	1366.16	-2230.12	-2841.64	-2385.36	-2032.81
Dividend Per Share	500.000	500.000	-	-	-	-
Gross Margin	36.99%	34.19%	38.51%	34.97%	33.39%	14.78%
Operating Margin	14.36%	10.12%	11.76%	7.16%	3.37%	-15.16%
Profit Margin	11.38%	12.68%	6.87%	7.22%	2.00%	-9.79%
Free Cash Flow Margin	-2.69%	9.73%	-14.72%	-21.44%	-26.88%	-30.56%
EBITDA	69,527	53,275	56,538	35,452	19,992	-4,749
EBITDA Margin	23.32%	19.46%	19.84%	14.22%	12.07%	-3.83%
D&A For EBITDA	26,711	25,582	23,027	17,600	14,414	14,068
EBIT	42,816	27,693	33,512	17,851	5,578	-18,817
EBIT Margin	14.36%	10.12%	11.76%	7.16%	3.37%	-15.16%
Effective Tax Rate	24.78%	24.05%	24.97%	8.95%	-	-
Advertising Expenses	-	1,221	705.83	324.5	83.11	141.16

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.